{"id":"W2521916949","doi":"10.1016/j.jtho.2016.08.056","title":"P1.34: First-Line Afatinib vs Gefitinib for Patients With EGFR Mutation-Positive Non-Small-Cell Lung Cancer: The LUX-Lung 7 Trial","year":2016,"lang":"en","type":"article","venue":"Journal of Thoracic Oncology","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"ca_institutions":"McGill University","funders":"","keywords":"Afatinib; Gefitinib; Medicine; Internal medicine; Lung cancer; Rash; Clinical endpoint; Oncology; Adverse effect; Adenocarcinoma; Randomized controlled trial; Gastroenterology; Cancer; Epidermal growth factor receptor","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001021585,0.001812864,0.00280584,0.0004016412,0.0003571304,0.001747287,0.001052636,0.001683395,0.00517906],"category_scores_gemma":[0.001280981,0.0005332919,0.003633911,0.0003833769,0.001149392,0.001781488,0.0005828486,0.005660343,0.001190113],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001360066,"about_ca_system_score_gemma":0.001155823,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001146798,"about_ca_topic_score_gemma":0.004947662,"domain_scores_codex":[0.9995888,0.0001580004,0.00002019102,0.00008642473,0.000034092,0.0001126347],"domain_scores_gemma":[0.9996037,0.00008569571,0.00007500656,0.00002726953,0.00002336966,0.000185027],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8869659,0.003526792,0.004346425,0.001914255,0.004818722,0.0002474402,0.0001583919,0.003906701,0.007216436,0.001199692,0.01251904,0.07318018],"study_design_scores_gemma":[0.9121454,0.06647444,0.01008152,0.0001422614,0.002717811,0.0003243713,0.0001070402,0.002017412,0.0008415658,0.001428575,0.003641721,0.00007785936],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9752741,0.01122244,0.0005372956,0.003186641,0.0008533048,0.000688002,0.003002076,0.0002788312,0.004957187],"genre_scores_gemma":[0.9823906,0.004301718,0.0007213323,0.001935922,0.0004657622,0.000711739,0.003938316,0.00006600982,0.00546857],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00517906,"threshold_uncertainty_score":0.01732564,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01489461468527154,"score_gpt":0.3992516621324371,"score_spread":0.3843570474471655,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}